InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2023-03-13 00:00:00 ET · period of report 2023-03-11 · accession 0001055726-23-000012 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-13 2023-03-11 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx — +59.7K 186.8K +47% —
D 2023-03-13 2023-03-11 INO Shea Jacqueline Elizabeth CEO, Dir F - Tax $1.13 -26.0K 160.8K -14% -$29.4K
D 2023-03-13 2023-03-11 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx $0.00 -59.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-11 M A 59,737 — 186,797 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2 Common Common Stock 2023-03-11 F D 25,980 $1.13 160,817 D — —
3 Derivative Restricted Stock Unit 2023-03-11 M D 59,737 $0.00 0 D — · — to — 59,737 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.